273 related articles for article (PubMed ID: 32374950)
1. Blastic plasmacytoid dendritic cell neoplasm with a history of cytopenia: A case report.
Yan M; Wang W; Cen X; Wang L; Sun Y; Wang B; Ou J; Nong L; Ren H; Zhu P; Wang M
Diagn Cytopathol; 2020 Nov; 48(11):1102-1106. PubMed ID: 32374950
[TBL] [Abstract][Full Text] [Related]
2. A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body.
Cui XB; Jin J; Pang XL; Li S; Liu CX; Li TT; Peng H; Zhang SM; Li L; Liang WH; Chen YZ; Li F
Int J Clin Exp Pathol; 2014; 7(7):4391-9. PubMed ID: 25120824
[TBL] [Abstract][Full Text] [Related]
3. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review.
Ding Y; Yang J; Lindsey K
Diagn Cytopathol; 2021 Feb; 49(2):E80-E83. PubMed ID: 32852895
[TBL] [Abstract][Full Text] [Related]
4. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
[TBL] [Abstract][Full Text] [Related]
5. Blastic plasmacytoid dendritic cell neoplasm and cerebral toxoplasmosis: a case report.
Florescu AM; Sørensen ALT; Nielsen HV; Tolnai D; Sjö LD; Larsen KL; Al-Karagholi MA
BMC Neurol; 2022 Jun; 22(1):233. PubMed ID: 35751052
[TBL] [Abstract][Full Text] [Related]
6. [Blastic plasmacytoid dendritic cell neoplasm accompanied by chronic myelomonocytic leukemia successfully treated with azacitidine].
Sukegawa S; Sakata-Yanagimoto M; Matsuoka R; Momose H; Kiyoki Y; Noguchi M; Nakamura N; Watanabe R; Fujimoto M; Yokoyama Y; Nishikii H; Kato T; Kusakabe M; Kurita N; Obara N; Hasegawa Y; Chiba S
Rinsho Ketsueki; 2018; 59(12):2567-2573. PubMed ID: 30626790
[TBL] [Abstract][Full Text] [Related]
7. Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.
Koerber RM; Held SAE; Vonnahme M; Feldmann G; Wenzel J; Gütgemann I; Brossart P; Heine A
J Cancer Res Clin Oncol; 2022 Mar; 148(3):743-748. PubMed ID: 34529129
[TBL] [Abstract][Full Text] [Related]
8. Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin.
Batta K; Bossenbroek HM; Pemmaraju N; Wilks DP; Chasty R; Dennis M; Milne P; Collin M; Beird HC; Taylor J; Patnaik MM; Cargo CA; Somervaille TCP; Wiseman DH
Leukemia; 2021 Nov; 35(11):3299-3303. PubMed ID: 33833384
[No Abstract] [Full Text] [Related]
9. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment with biweekly CHOP for bone marrow relapse of blastic plasmacytoid dendritic cell neoplasm].
Ono K; Ise M; Ikebe D; Sato A; Wang X; Sugawara T; Tsujimura H; Itami M; Kumagai K
Rinsho Ketsueki; 2017; 58(2):150-154. PubMed ID: 28321093
[TBL] [Abstract][Full Text] [Related]
11. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
Shi Y; Wang E
Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
[TBL] [Abstract][Full Text] [Related]
12. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
[TBL] [Abstract][Full Text] [Related]
13. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
[TBL] [Abstract][Full Text] [Related]
14. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
Riaz W; Zhang L; Horna P; Sokol L
Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
[TBL] [Abstract][Full Text] [Related]
15. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) in leukaemic phase without skin lesions: a diagnostic and management challenge.
Murphy N; Owens D; Hinds E; Nelson N
Pathology; 2019 Jun; 51(4):439-441. PubMed ID: 31003841
[No Abstract] [Full Text] [Related]
16. Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome.
Yasuda H; Takaku T; Tomomatsu J; Hosone M; Tanaka H; Komatsu N
Intern Med; 2014; 53(23):2717-20. PubMed ID: 25447656
[TBL] [Abstract][Full Text] [Related]
17. Blastic plasmacytoid dendritic cell neoplasm.
Lim D; Goodman H; Rademaker M; Lamont D; Yung A
Australas J Dermatol; 2013 May; 54(2):e43-5. PubMed ID: 23582004
[TBL] [Abstract][Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
Lim MS; Lemmert K; Enjeti A
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
[TBL] [Abstract][Full Text] [Related]
19. Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents.
Wang S; Wang X; Liu M; Bai O
Ann Hematol; 2018 Apr; 97(4):563-572. PubMed ID: 29455234
[TBL] [Abstract][Full Text] [Related]
20. Dendritic Cell Leukemia: a Review.
Tsagarakis NJ; Paterakis G
Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]